[2-(2-Amino-phenyl)-1-hydroxy-1-phosphono-ethyl]-phosphonic acid

ID: ALA414849

Cas Number: 427899-21-6

PubChem CID: 9994754

Product Number: N612204, Order Now?

Max Phase: Preclinical

Molecular Formula: C8H13NO7P2

Molecular Weight: 297.14

Molecule Type: Small molecule

In stock!

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccccc1CC(O)(P(=O)(O)O)P(=O)(O)O

Standard InChI:  InChI=1S/C8H13NO7P2/c9-7-4-2-1-3-6(7)5-8(10,17(11,12)13)18(14,15)16/h1-4,10H,5,9H2,(H2,11,12,13)(H2,14,15,16)

Standard InChI Key:  VJXYJONFUZXZJZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    9.1373    0.1330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1359   -0.6946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8489   -1.1075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5682   -0.6941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5651    0.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8469    0.5457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2774    0.5529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9940    0.1440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4056    0.8590    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   12.8099    1.5766    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1224    0.4507    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.6893    1.2684    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5725   -0.5637    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   12.6999   -0.2659    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1555   -1.2741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8623   -0.1439    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2826   -0.9836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8431    1.3707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  8  9  1  0
  4  5  1  0
  9 10  1  0
  2  3  1  0
  9 11  1  0
  5  6  2  0
  9 12  2  0
  6  1  1  0
  8 13  1  0
  1  2  2  0
  8 14  1  0
  5  7  1  0
 13 15  1  0
  3  4  2  0
 13 16  2  0
  7  8  1  0
 13 17  1  0
  6 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA414849

    NE21650

Associated Targets(Human)

FDPS Tclin Farnesyl diphosphate synthase (1240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PPase1 Vacuolar-type proton translocating pyrophosphatase 1 (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dictyostelium discoideum (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 297.14Molecular Weight (Monoisotopic): 297.0167AlogP: -0.19#Rotatable Bonds: 4
Polar Surface Area: 161.31Molecular Species: ACIDHBA: 4HBD: 6
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: 0.65CX Basic pKa: 3.64CX LogP: -2.28CX LogD: -6.27
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.33Np Likeness Score: 0.16

References

1. Kotsikorou E, Song Y, Chan JM, Faelens S, Tovian Z, Broderick E, Bakalara N, Docampo R, Oldfield E..  (2005)  Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase.,  48  (19): [PMID:16162013] [10.1021/jm058220g]
2. Dunford JE, Kwaasi AA, Rogers MJ, Barnett BL, Ebetino FH, Russell RG, Oppermann U, Kavanagh KL..  (2008)  Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.,  51  (7): [PMID:18327899] [10.1021/jm7015733]
3. Hounslow AM, Carran J, Brown RJ, Rejman D, Blackburn GM, Watts DJ..  (2008)  Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs.,  51  (14): [PMID:18590315] [10.1021/jm7015792]
4. Song Y, Chan JM, Tovian Z, Secrest A, Nagy E, Krysiak K, Bergan K, Parniak MA, Oldfield E..  (2008)  Bisphosphonate inhibitors of ATP-mediated HIV-1 reverse transcriptase catalyzed excision of chain-terminating 3'-azido, 3'-deoxythymidine: a QSAR investigation.,  16  (19): [PMID:18789701] [10.1016/j.bmc.2008.08.047]

Source